Toth Financial Advisory Corp decreased its holdings in shares of ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report) by 24.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,656 shares of the exchange traded fund’s stock after selling 2,799 shares during the period. Toth Financial Advisory Corp owned 0.72% of ProShares Ultra Nasdaq Biotechnology worth $439,000 as of its most recent SEC filing.
Separately, Jane Street Group LLC grew its stake in shares of ProShares Ultra Nasdaq Biotechnology by 8.4% in the 3rd quarter. Jane Street Group LLC now owns 4,803 shares of the exchange traded fund’s stock worth $306,000 after buying an additional 374 shares during the last quarter.
ProShares Ultra Nasdaq Biotechnology Trading Down 1.2 %
Shares of NASDAQ:BIB opened at $54.49 on Friday. The stock has a fifty day simple moving average of $54.09 and a two-hundred day simple moving average of $60.71. ProShares Ultra Nasdaq Biotechnology has a 12-month low of $47.19 and a 12-month high of $69.56.
ProShares Ultra Nasdaq Biotechnology Increases Dividend
About ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology (the Fund) seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from the inverse of the return of the Dow Jones United States Basic Materials Index (the Index) for that period.
See Also
- Five stocks we like better than ProShares Ultra Nasdaq Biotechnology
- The Most Important Warren Buffett Stock for Investors: His Own
- Bloom Energy: Powering the Future With Decentralized Energy
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- What is Put Option Volume?
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding BIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB – Free Report).
Receive News & Ratings for ProShares Ultra Nasdaq Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Ultra Nasdaq Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.